Scott A. Siegel
Geen lopende functies
Oorsprong van het eerstegraads netwerk van Scott A. Siegel
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Private Company | Food: Specialty/Candy | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Scott A. Siegel via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
ACCELRYS, INC. | Packaged Software | Chairman | |
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ. | Biotechnology | Director/Board Member | |
Florida State University | College/University | Doctorate Degree | |
CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chairman | |
E I DU PONT DE NEMOURS AND CO | Chemicals: Agricultural | Corporate Officer/Principal | |
Linguagen Corp.
Linguagen Corp. Pharmaceuticals: OtherHealth Technology Linguagen Corp. researches and develops oral medicines. The firm also develops taste blockers and enhancers. The company was founded by Robert Margolskee in 1995 and is headquartered in Cranbury, NJ. | Pharmaceuticals: Other | Director/Board Member | |
Genencor International, Inc.
Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Biotechnology | Director/Board Member | |
University of Wisconsin | College/University | Doctorate Degree | |
University of Rhode Island | College/University | Doctorate Degree | |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Pharmaceuticals: Major | President | |
NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman | |
Pharmacopeia LLC
Pharmacopeia LLC Pharmaceuticals: MajorHealth Technology Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ. | Pharmaceuticals: Major | Chairman | |
SUNY College of Environmental Science | College/University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 18 |
Sectoraal
Health Technology | 10 |
Consumer Services | 5 |
Technology Services | 2 |
Finance | 2 |
Process Industries | 2 |
Operationeel
Director/Board Member | 6 |
Chairman | 5 |
President | 3 |
Doctorate Degree | 3 |
Chief Tech/Sci/R&D Officer | 3 |
Sterkste connecties
Insiders | |
---|---|
Joseph A. Mollica | 14 |
Robert W. Bryant | 5 |
- Beurs
- Insiders
- Scott A. Siegel
- Bedrijfsconnecties